Pancreatic Cancer Research

ResearcherHerlev HospitalActive in the last 2 years

Pia Helene Klausen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 6 November 2026

Matched on ORCID iD 0000-0001-9386-9167; OpenAlex author ID A5072164808. Sources: ClinicalTrials.gov.

Their work

Papers
3 (first author 0, last author 2)
Trials
1 (principal investigator on 1)
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2021: 1 trial · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Regulatory elements in the Sox9 locus license the initiation of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.celrep.2026.117176↗
  2. EUS-guided biopsies versus surgical specimens for establishing patient-derived pancreatic cancer organoids: a systematic review and meta-analysis. Last author DOI 10.1016/j.gie.2024.04.012↗
  3. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer. Last author DOI 10.3390/cancers15143677↗

Trials 1

  1. Pharmacotyping of Pancreatic Patient-derived Organoids Principal investigator NCT05196334↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peter Vilmann · 3 shared papers, 2023–2026 · strength 0.64
  2. Simon Ezban Grützmeier · 2 shared papers, 2023–2024 · strength 0.41
  3. Bojan Kovacevic · 2 shared papers, 2023–2024 · strength 0.41
  4. Marta Ballester · 1 shared paper, 2026 · strength 0.23
  5. Elisa Espinet · 1 shared paper, 2026 · strength 0.23
  6. H. Carlo Maurer · 1 shared paper, 2026 · strength 0.23
  7. Luís Arnes · 1 shared paper, 2026 · strength 0.23
  8. Albin Sandelin · 1 shared paper, 2026 · strength 0.23
  9. Hanne Grossjohann · 1 shared paper, 2023 · strength 0.15
  10. Estrid Vilma Solyom Høgdall · 1 shared paper, 2023 · strength 0.15
  11. Carsten Palnæs Hansen · 1 shared paper, 2023 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.